Sargent Investment Group’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,092
Closed -$5.8K – 234
2024
Q4
$5.8K Sell
1,092
-860
-44% -$4.85K ﹤0.01% 235
2024
Q3
$8.7K Hold
1,952
– – ﹤0.01% 216
2024
Q2
$51.7K Sell
1,952
-23
-1% -$542 0.01% 214
2024
Q1
$54.1K Buy
1,975
+155
+9% +$4.92K 0.01% 197
2023
Q4
$44.2K Sell
1,820
-255
-12% -$4.52K 0.01% 206
2023
Q3
$41.9K Sell
2,075
-8
-0.4% -$205 0.01% 200
2023
Q2
$61.5K Buy
2,083
+56
+3% +$1.59K 0.01% 195
2023
Q1
$51.1K Buy
2,027
+515
+34% +$16.6K 0.01% 193
2022
Q4
$47.9K Buy
1,512
+19
+1% +$599 0.01% 189
2022
Q3
$47K Buy
1,493
+465
+45% +$16K 0.01% 181
2022
Q2
$31K Buy
+1,028
New +$94.2K 0.01% 183

Other funds holding LONA

Sargent Investment Group's LONA Position: Q1 2025 in Review

Sargent Investment Group sold out of LeonaBio Inc (LONA) in Q1 2025, closing a stake of 1,092 shares — an estimated $5.8K sold.

Sargent Investment Group first reported a position in LONA in Q2 2022 and held it in 11 quarters. The position peaked at $61.5K in Q2 2023. 53 funds tracked by Wall St. Rank hold LONA as of Q1 2025.

  • Sargent Investment Group reported no remaining LeonaBio Inc position as of Q1 2025 after selling out during the quarter.
  • Sargent Investment Group sold 1,092 LeonaBio Inc shares in Q1 2025, an estimated $5.8K.
  • Sargent Investment Group first reported a position in LeonaBio Inc in Q2 2022 and held it in 11 quarters.
  • Sargent Investment Group's LeonaBio Inc position peaked at $61.5K in Q2 2023.
  • 53 funds tracked by Wall St. Rank held LeonaBio Inc as of Q1 2025.

Based on Sargent Investment Group's 13F filing for Q1 2025, filed 5 May 2025.